Lamentamos pelo inconveniente. from Cornell University and a J.D. Dr. Schleifer, together with Regenerons founding scientist, Dr. Yancopoulos, built and managed the company over the past 35 years. He has nearly 20 years of experience in the biopharmaceutical industry, where he has held a variety of strategic, business development and finance roles, including in Genentechs Business Development and Corporate Finance departments and in investment banking and equity research at Morgan Stanley and Robertson Stephens. VA. He previously held roles on the tax teams at Arthur Anderson, Ernst & Young, and Diageo, and he currently serves as secretary and member of the board of trustees at Intensive Therapeutics, a 501c3 non-profit organization that provides therapy services to children with special needs. Previously, he held roles and responsibilities at Regeneron across R&D and business development. Andrew Murphy, Ph.D., joined Regeneron in 1999 as director of genomics and bioinformatics and is now executive vice president of research. from the Aristotle University of Thessaloniki in Greece and then received his Ph.D. in microbiology at Columbia University. Most recently she was VP, global head of DE&I at Zendesk. Zoran Berkovic joined Regeneron in 2017 and is senior vice president, financial planning & analysis, where he has grown the scope of the group and fostered a culture of accountability. Dr. Olson received his B.S. Mark Volpe, J.D., joined Regeneron in 2012 and is senior vice president, tax. Collectively, through integration of pharmacology with modeling and other quantitative methods, the functions within pharmacometrics play a central role in dose selection from first-in-human studies through global market applications as well as post-approval activities. Leonard (Len) Brooks joined Regeneron in 2013 and serves as senior vice president, treasurer. Prior to working at Regeneron, Mr. REGENERON PHARMACEUTICALS, INC. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Dr. Zoghbi is the director of the Jan and Dan Duncan Neurological Research Institute at Texas Childrens Hospital, and is a Howard Hughes Medical Institute investigator. Si vous continuez voir ce Senior Vice President, Head of Accounting and Controller. CA. Read what they think about their salaries on our Compensation FAQ page for Regeneron. GSK #bestplacetowork #careers, The average Regeneron salary ranges from approximately $52,103 per year for, Regeneron employees attributed a compensation and benefits rating of 4.2/5 stars to their company. in biology from the University of Massachusetts. and Ph.D. in chemical engineering from the University of Virginia. Gerald Carreau joined Regeneron in 2008 and serves as senior vice president, commercial scale manufacturing and manufacturing technology. Ms. Ravetti leads the Global Pharmaceutical Legal Operations team, a multidisciplinary team providing legal advice on the clinical development and commercialization of Regenerons products,including advice on R&D, regulatory matters, market access, product launches, lifecycle planning, and healthcare law compliance. Boyce F. Martin, Jr., Chief Judge Emeritus, U.S. Court of Appeals for the Sixth Circuit. He earned his B.S. He previously held roles in process development and preclinical manufacturing, clinical manufacturing and manufacturing sciences. Regeneron salary trends based on salaries posted anonymously by Regeneron employees. and Ph.D. from the University of Wales in the UK. Our leadership team possesses deep and diverse industry knowledge, a passion for science and a shared commitment to help transform lives. Gang Chen, Ph.D., is the head of protein expression sciences (PES) in his role as senior vice president. Regeneron employees rate the overall compensation and benefits package 4.2/5 stars. Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Human Resources responsibilities. Lynn Macdonald, Ph.D., joined Regeneron in 1999 and serves as senior vice president, research. Prior to joining Regeneron, she was chief business officer of Constellation Pharmaceuticals. Dr. Baras received his B.S., MBA and M.D. Chris Fenimore joined Regeneron in 2003 and, as the current head of accounting and controller, has global responsibility for SEC reporting,accounting and accounting operations, and internal control over financial reporting, administration of financial systems, accounts payableandpayroll. Dr. Thompson is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Association of American Physicians. In addition to leading manufacturing operations in New Yorks capital region, Mr. Yocums sphere of influence extends beyond manufacturing to encompass all aspects of our quality culture. Jennifer McNay, Ph.D., joined Regeneron in 2000 and serves as senior vice president of chemistry, manufacturing and controls (CMC) regulatory sciences and industrial affairs. Prior to joining Regeneron, Dr. Murphy worked for seven years at Cadus Pharmaceuticals. This role will report to the CFO and have close interaction with the entire C-suite and internal ZipRecruiter ATS Jobs for ZipSearch/ZipAlerts - 1 day ago, Pure Archery Group - Eugene He is a member of the National Academy of Sciences, the National Academy of Medicine, the Royal Society of London and the Royal Society of Canada. Senior Vice President, Protein Expression Sciences. Prior to joining the industry, Ms. Lozner was a litigation attorney and served as a law clerk for Hon. She is a former member of the supervisory board of Royal Philips Electronics and the board of directors of Decibel Therapeutics, Inc. Scribe Therapeutics - Alameda This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. He served as president and chief executive officer of Memorial SloanKetteringCancer Center (MSK) from 2010 until September 2022 and continues to oversee the Craig Thompson Lab, which studies cellular metabolism and its role in disease. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. The estimated total pay for a Senior Director at Regeneron is $376,244 per year. Joseph J. LaRosa joined Regeneron in 2011 and is currently executive vice president, general counsel and secretary. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. Senior Vice President, Immuno-Oncology and Head of Bispecifics. Ron Wang, Ph.D., joined Regeneron in 1999 andcurrentlyserves as senior vice president of quality control, leading a global functionthat leveragesstrategic business partnerships and automation to provide back-up lab capabilities,protect the supply chain and optimize resources and lab capacity. Research & Science Based on 1040 salaries Research Associate 187 salaries Scientist 119 salaries View More Engineering Based on 355 salaries QC Analyst 28 salaries Engineering Co-Op 12 salaries View More Senior Vice President, Public Policy and Government Affairs. Hanne Bak, Ph.D., joined Regeneron in 2004 and serves as senior vice president, preclinical manufacturing and process development (PMPD). She was previously at Pfizer where she held the positions of vice president, business operations and analytics, and, prior to that, vice president, strategic alliance and development operations lead. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. Prior to joining Regeneron, Ms. McCourt worked at Axovant, a clinical-stage biopharmaceutical company, where she was president and chief operating officer. She earned a B.S. As Executive Vice President, Research at REGENERON PHARMACEUTICALS, INC., Andrew J. Murphy Ph.D. made $7,146,830 in total compensation. $20.9K. Senior Vice President, Technical Operations. Senior Vice President, IT and Chief Information Officer. From 2009 to 2019, Mr. Ryan served as a director of Citizens Financial Group, Inc. Dr. Schleifer founded the company in 1988 and has been a director and its president and chief executive officer since its inception. Other. If you continue to see this pour nous faire part du problme. Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Johnathan M. Lancaster, M.D., Ph.D., joined Regeneron in 2019 as a vice president and now serves as SVP and head of global medical affairs. Prior to joining Regeneron, Ms. Ravetti spent 10 years at Pfizer in various positions of increasing responsibility, and she was previously an Associate at the law firm of Sullivan and Cromwell. Prior to his current role, he served as Regenerons vice president of financial planning, and prior to joining Regeneron, he was vice president of finance at Mojave Therapeutics, Inc. Executive Vice President, Global Clinical Development. Israel Lowy, M.D., Ph.D., joined Regeneron in 2010 as vice president, and now serves as senior vice president, translational and clinical sciences, oncology. Sally A. Paull joined Regeneron in 2016 and now serves as executive vice president, human resources. Dr. Zoghbi has been a director of the company since 2016. Know Your Worth. Prior to joining Regeneron, Dr. Lowy was at Medarex for eight years. Regeneron's people make us who we are, and we are truly more than a company - we're a community. and Ph.D. in chemical engineering from Danmarks Tekniske Universitet (Technical University of Denmark). Read what they think about their salaries on our Compensation FAQ page for Regeneron. From 1998 until 2004, he held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. The estimated total pay for a Vice President at Regeneron is $419,353 per year. degree from Duke University and his Ph.D. in biochemistry from Brandeis University, then conducted post-doctoral research and was a faculty member at the University of California, San Francisco. Amgen The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. Mr. Ryan managed Chases worldwide retail bank between 1984 and 1990. Regeneron Wir entschuldigen uns fr die Umstnde. enva un correo electrnico a Smita Pillai joined Regeneron as our first chief diversity, equity and inclusion (DEI) officer in 2021. Prior to joining Regeneron, Mr. Austin worked for 14 years at Amgen in various roles of increasing responsibility, including assisting in starting operations at the companys Longmont, Colorado, and Juncos, Puerto Rico sites, and spent time working at both Novartis and Abbott Laboratories. Dr. Zoghbi is a member of the National Academy of Sciences, the Institute of Medicine, and the American Association for the Advancement of Science. from Boston University School of Law. Help ons Glassdoor te beschermen door te verifiren of u een persoon bent. Feb 1, 2023 11:58am. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Regeneron salary trends based on salaries posted anonymously by Regeneron employees. 4 percents of the salary are above $200K, 15 percents of the salary are between $150K and $200K, 56 percents of the salary are between $100K and $150K, 25 percents of the salary are less than $100k We found the records are from 1 employers: Mastercard - Arlington She is a former executive-in-residence in the Department of Management and Human Resources and former dean and John W. Berry, Sr. Dr. Soltys received his B.S. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. REGENERON PHARMACEUTICALS, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Brian Zambrowicz, Ph.D., joined Regeneron in 2015 and serves as executive vice president, functional genomics and chief, VelociGene operations. , Senior Vice President, Global Patient Safety. The estimated additional pay is $171,268 per year. Regental Professor of Molecular Genetics and Internal Medicine, Director, Erik JonssonCenter for Molecular Genetics, The University of Texas Southwestern Medical Center at Dallas. It also provides Dup REGENERON PHARMACEUTICALS, INC. Vice President of Laboratory, Top Division Information Technology Executive, Director/Vice President, Data Science and Technology Platforms, Vice President of Engineering - Financials - East Coast US, Vice President of Laboratory Salaries with a Master's Degree or MBA, Vice President of Laboratory Salaries with a JD, MD, PhD or Equivalent, Detailed skills and competency reports for specific positions. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. Takeda Sing has been a director of the company since 1988. from Binghamton University. Mr. Volpe received an A.S. in accounting from Suffolk County Community College, followed by a B.A. in International Relations from the University of Delaware. Nouhad Husseini joined Regeneron in 2011 and is head of business development, overseeing the companys efforts to execute new strategic collaborations and licensing agreements. Having joined the company in 1999, Dr. Chen has held scientific roles of increasing responsibility over his 23 years with Regeneron. Dr. Brown is a member of the National Academy of Sciences, the National Academy of Medicine and the Royal Society of London. Average salaries for Regeneron Vice President: [salary]. #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. from Northwestern University. He received his MBA from Northwestern University Kellogg School of Management. Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel. David Snow joined Regeneron in 2020 and is senior vice president and global head of the Dupixent(dupilumab) franchise. He earned his B.S. at the State University of New York at Albany and a J.D. Dr. Hirshberg completed his undergraduate and medical degrees at the Hebrew University and is board certified in internal medicine, following his residency at the Hadassah Medical center in Jerusalem. Prior to joining Regeneron, she worked at Raytheon Engineers & Construction, Genzyme Corporation and Repligen Corporation. Executive Vice President and General Manager, Industrial Operations and Product Supply. He has prior experiencein healthcare industry-focused venture capital and investment banking roles,as well as serving as an audit seniorat KPMG. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. an. Find high paying available jobs at Regeneron Pharmaceuticals, Inc.For expert network information on Regeneron Pharmaceuticals, Inc compensation and careers, use Ladders $100K + Club. She started her career at Regeneron as a research engineer working in the purification development group within PMPD and has subsequently held roles of increasing responsibility. She previously led communication for the cardiovascular & metabolism therapeutic area and global commercial strategy organization at Janssen, J&Js pharmaceutical division. Senior Vice President, Global Medical Affairs. Senior Vice President, Associate General Counsel. He previously served as the regional CFO for Japan, Australia and New Zealand at Mylan, as well as other roles, and he worked at Cephalon in financial roles. Abbott He served as executive vice president and chief scientific officer at Genentech, Inc. from 2003 to 2011. Salary.com's CompAnalyst platform offers: These charts show the average base salary (core compensation), as well as the average total cash compensation for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. in the United States. In addition, his team oversees regulatory functions including labeling and advertising/promotion and compliance. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. You are now leaving Regeneron.com to visit another Regeneron website. Senior Vice President, Translational and Clinical Sciences, Oncology. Since 1994, she has been a professor in the Departments of Pediatrics, Molecular and Human Genetics, and Neurology and Neuroscience at Baylor College of Medicine. He has been the president of Stanford University since 2016. He is a primary architect of Regenerons cancer immunotherapy program. All trademarks mentioned are the property of their respective owners. Drs. Ms. Gilooly has held positions of increasing responsibility in validation and quality assurance and operations. Senior Vice President, Clinical Sciences General Medicine. . Merck Bitte helfen Sie uns, Glassdoor zu schtzen, indem Sie besttigen, dass Sie Dr. Brown has been a director of the company since 1991. Abbvie . Senior Vice President, Early Clinical Development and Experimental Sciences. Before that, he was assistant professor of medicine and microbiology at Mount Sinai School of Medicine. Toggle navigation Demo Home For YouPersonal Menu For EmployersBusiness Menu Survey CatalogServey Menu Prior to joining Regeneron, Dr. Stahl received his B.S. She oversees global HR systems and processes and is expanding HR operations to support employees in a growing number of countries outside the U.S. How accurate is this most likely Total Pay range (base + additional) of $329K-$554K/yr? Each salary is associated with a real job position. Previously, Dr. Olson was a scientist at MicroGeneSys and Johnson & Johnsons RW Johnson Pharmaceutical Research Institute. Melissa Lozner, J.D., joined Regeneron in 2022 and serves and as senior vice president, chief compliance officer. from New York University. Thank you to our incredible colleagues for making this truly a great place to work and a place where passion meets opportunity. Prior to joining Regeneron, he held senior leadership positions in drug safety assessment at Genentech and Bristol-Myers Squibb. Dr. Stahl started his career at Regeneron as a staff scientist in discovery research working on cytokine receptor signaling, and he spearheaded the invention and development of Regenerons Trap Technology. Dr. Goldstein has been a director of the company since 1991. Mr. Brooks leads a team responsible for optimizing liquidity and use of capital resources, safeguarding Regenerons cash and investment portfolio, corporate risk management and maintaining strong relationships with financial institutions, insurance providers and rating agencies. Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de From 2008 until 2013, Mr. Ryan served as a non-executive director of the Royal Bank of Scotland Group plc. Dr. Hughes worked for Sunovion Pharmaceuticals, FORUM Pharmaceuticals, and spent 14 years at Pfizer, where she held various roles of increasing responsibility. | Regeneron's CEO, Leonard Schleifer, M.D., Ph.D., collected a . Of this total $724,500 was received as a salary, $819,410 was received as a bonus, $3,347,323 was received in stock options, $2,231,397 was awarded as stock and $24,200 came from other types of compensation. Salary Range (annually) $75,700.00 - $123,500.00 R17524 Seniority level Mid-Senior level Employment type Full-time Job function Research, Analyst, and Information Technology Industries. from the University of Wisconsin-Madison and his Ph.D. from the University of Washington. Average salary for PDR Network Vice President Business Development in West Point, PA: [salary]. He received his B.S. He received his Ph.D. in medicine and molecular biology from Kings College, University of Cambridge and his M.D. in biology from the University of Science and Technology of China and his Ph.D. in cell biology from the University of Washington. Christos Kyratsous, Ph.D., joined Regeneron in 2011 and is the senior vice president of research. How much do Regeneron employees make? This position will direct all areas of Human Resource administration including; recruiting, salary administration, associate services, associate benefits, management development/training and labor American Association of Motor Vehicles - Arlington Average salary for IPSEN Vice President Human Resources in Wherstead, England: [salary]. Dr. Weinreich was previously the Senior Vice President and head of global development for specialty medicine at Bayer Pharmaceuticals. para nos informar sobre o problema. real person. Former Executive-in-Residence in the Department of Management and Human Resources at the Max M. Fisher College of Business, The Ohio State University. COMPANY SIZE 5,000 to 9,999 employees INDUSTRY Biotechnology/Pharmaceuticals FOUNDED 1988 WEBSITE https://www.regeneron.com/ Similar Jobs Respiratory Therapist - PRN - Ardmore Mercy Ardmore, OK 11 days ago Apply RRT Focus Staff Ardmore, OK 8 days ago He received his B.S. Regeneron #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. She received a J.D. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. The estimated hourly pay at Regeneron ranges from approximately $13.69 per hour for Software Engineer to $71.96 per hour for IT Manager.. Browse 100 estimated salaries at Regeneron in the United States Prior to BOL, he spent 12 years at AstraZeneca/MedImmune in roles of increasing responsibility, ultimately building and overseeing the cardiovascular renal and metabolism clinical therapeutic area at MedImmune. from National Taiwan University and his Ph.D. from Harvard University. Average Regeneron Vice President yearly pay in the United States is approximately $183,000, which is 24% above the national average. Dr. Tessier-Lavigne has been a director of the company since 2011. Prior to joining Regeneron, Mr. Calabro spent 18 years at UST, Inc., where he held positions of increasing responsibility within internal audit, ultimately serving as director of internal. VA. He also is a member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute. He has driven an enhanced company focus on big data, innovation and strategic IT investments that support Regenerons mission. Between 2004 and 2006, Mr. Van Plew held positions of increasing responsibility at Chiron Biopharmaceuticals, most recently as senior director, Vacaville operations. from Duke University. Before joining Regeneron, Dr. Hirshberg was executive vice president, chief medical officer and head of global development at BOL Pharma, a biotech developing medical cannabis therapeutics, where he directed preclinical and clinical development, regulatory, pharmacovigilance and medical affairs. She was previously executive vice president, chief human resources ocer at Inova Health System. Prior to his time at MSK,Dr. Thompsonmade significant contributions to cancer research as a physician and clinical investigator. Regeneron Pharmaceuticals salaries are collected from government agencies and companies. Anyone wants to share the salary range for VP at the pharma and biotech? Daniel Van Plew joined Regeneron in 2007 and has served as executive vice president and general manager, industrial operations and product supply since January 2016. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,.